Skip to main content
Log in

Inhibition of gastrointestinal motility by MPTP via adrenergic and dopaminergic mechanisms

  • Motility, Nerve-Gut Interactions, Hormones, And Receptors
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was injected intraperitoneally in mice and caused an acute inhibition (of over 60%) of gastrointestinal motility, which was measured by the transit of charcoal. This inhibition was not related to conversion of MPTP to MPP+. Administration of the β-adrenergic blocker propranolol significantly reduced, but did not completely block, the effect of MPTP. The dopaminergic blocker haloperidol also partly reversed the effects of MPTP. When these blockers were administered together, the action of MPTP was fully blocked. The results indicate that the toxin acted by releasing catecholamines (presumably norepinephrine and dopamine), thereby inhibiting motility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kopin IJ, Markey SP: MPTP toxicity: Implications for research in Parkinson's disease. Annu Rev Neurosci 11:81–96, 1988

    Google Scholar 

  2. Gerlach M, Riederer P, Przuntek H, Youdim MB: MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease. Eur J Pharmacol 208:273–286, 1991

    Google Scholar 

  3. Fuller RW, Hemrick-Luecke SK: Depletion of norepinephrine in mouse heart by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), mimicked by 1-methyl-4-phenylpyridinium and not blocked by deprenyl. Life Sci 39:1645–1650, 1986

    Google Scholar 

  4. Ambrosio S, Blesa R, Mintenig GM, Palacios-Araus L, Mahy M, Gual A: Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines in heart, adrenal gland, retina an caudate nucleus of the cat. Toxicol Lett 44:1–6, 1988

    Google Scholar 

  5. Szabo S, Brown A, Pihan G, Dali H, Neumeyer L: Duodenal ulcer induced by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine). Proc Soc Exp Biol Med 180:567–571, 1985

    Google Scholar 

  6. Alkadhi KA, Hogan YH: Effects of 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine (MPTP) on ganglionic transmission. J Auton Pharmacol 12:15–23, 1992

    Google Scholar 

  7. Eaker EY, Bixler GB, Dunn AJ, Moreshead WV, Mathias JR: Chronic alterations in jejunal myoelectric activity due to MPTP. Am J Physiol 253:G809-G815, 1987

    Google Scholar 

  8. Mangla JC, Pihan G, Brown HA, Rattan S, Szabo S: Effect of duodenal ulcerogens cysteamine, mepirizole, and MPTP on duodenal myoelectric activity in rats. Dig Dis Sci 34:537–542, 1989

    Google Scholar 

  9. Hanani M: Rapid effects of MPTP in the mouse colon. Eur J Pharmacol 175:273–277, 1990

    Google Scholar 

  10. Wong CL: The effect of nalbuphine on gastrointestinal transit in mice, Eur J Pharmacol 135:219–223, 1986

    Google Scholar 

  11. Daniel EE: Pharmacology of adrenergic, cholinergic, and drugs acting on other receptors in gastrointestinal muscle,In Handbook of Experimental Pharmcology, Vol 59/2, Mediators and Drugs in Gastrointestinal Motility, II. G Bertaccini (ed). New York, Springer, 1982, pp 249–322

    Google Scholar 

  12. Keshavarzian A, Wibowo A, Gordon JH, Fields JZ: MPTP-induced duodenal ulcers in rat. Prevention by reuptake blockers for serotonin and norepinephrine, but not dopamine. Gastroenterology 98:554–560, 1990

    Google Scholar 

  13. Wilson SP, Beeler JF: Catecholamine depletion and accumulation of effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenyl-pyridinium (MPP+) in adrenal medullary chromaffin cells. Neurochem Int 13:333–343, 1988

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by a grant from the Joint Research Fund of the Hebrew University and Hadassah.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haskel, Y., Hanani, M. Inhibition of gastrointestinal motility by MPTP via adrenergic and dopaminergic mechanisms. Digest Dis Sci 39, 2364–2367 (1994). https://doi.org/10.1007/BF02087652

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02087652

Key words

Navigation